About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Not long after Novo Nordisk received an untitled letter from the FDA disputing certain elements of the first TV spot for its ...

Vanda Pharmaceuticals’ seven-year ambition to score a coveted label expansion for sleep drug Hetlioz has taken an unusual ...

With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for ...

Collegium Pharmaceutical has tapped an appropriately glitzy star as the face of a new campaign spotlighting the bright side of life with attention-deficit/hyperactivity disorder (ADHD). | Collegium ...

Sanofi is betting $1.53 billion on a novel drug from Sino Biopharmaceutical, securing global rights to a first-in-class ...

Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in ...

One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Kraemer discussed how patients inspire his work, his advice for ...

NoA Health has appointed Louisa Lee as CEO, putting the former Novo Nordisk and Pfizer employee at the head of the creative ...

Dr. McDreamy has signed onto yet another cancer awareness initiative. | Dr. McDreamy has signed onto yet another cancer ...